Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. Februar 2019 08:00 ET | Quelle: Hoth Therapeutics, Inc

Hoth Therapeutics Inc. Announces the Addition of Dr. Adam Friedman, M.D. to the Company's Scientific Advisory Board

NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics, Inc.(NASDAQ:HOTH), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from...
20. Februar 2019 17:15 ET | Quelle: Hoth Therapeutics, Inc

Hoth Therapeutics Inc. Announces Closing of Initial Public Offering

NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics Inc. (NASDAQ: HOTH), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from...
20. Februar 2019 16:30 ET | Quelle: Hoth Therapeutics, Inc

Hoth Therapeutics Inc. Announces Closing of Initial Public Offering

NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics Inc. (“Hoth” or the “Company”), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients...
15. Februar 2019 08:00 ET | Quelle: Hoth Therapeutics, Inc

Hoth Therapeutics Inc. Announces Pricing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol “HOTH”

NEW YORK, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics Inc. (“Hoth” or the “Company”), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients...